Glaukos Corporation has appointed Raphaél Ervinckx as Vice President and General Manager for the EMEAI region, marking a strategic move to support the company’s continued international growth.
Raphaël Ervinckx brings extensive experience in the ophthalmology sector, most recently serving as Vice President Western Europe at BVI Medical. He joined the BVI leadership team following its 2019 acquisition of PhysIOL, the Belgium-based intraocular lens innovator, where he was instrumental in scaling the business and expanding into new markets.
“I’m excited to begin this new chapter with Glaukos,” said Raphaël Ervinckx. “The company’s commitment to innovation, research, and patient-centric care aligns closely with my values. I look forward to contributing to its mission and strengthening relationships across the EMEAI region.”
With a strong background in sales, marketing and market access, Raphaël Ervinckx is well-positioned to help Glaukos seize opportunities in glaucoma, corneal health and other vision-related conditions.
FURTHER INFORMATION:
Glaukos
W: www.glaukos.com/en-uk/
